標(biāo)題: Titlebook: Clinical Cases in Atopic Dermatitis; Nicholas Brownstone,Wilson Liao,Tina Bhutani Book 2024 The Editor(s) (if applicable) and The Author(s [打印本頁] 作者: 瘦削 時(shí)間: 2025-3-21 19:55
書目名稱Clinical Cases in Atopic Dermatitis影響因子(影響力)
書目名稱Clinical Cases in Atopic Dermatitis影響因子(影響力)學(xué)科排名
書目名稱Clinical Cases in Atopic Dermatitis網(wǎng)絡(luò)公開度
書目名稱Clinical Cases in Atopic Dermatitis網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Clinical Cases in Atopic Dermatitis被引頻次
書目名稱Clinical Cases in Atopic Dermatitis被引頻次學(xué)科排名
書目名稱Clinical Cases in Atopic Dermatitis年度引用
書目名稱Clinical Cases in Atopic Dermatitis年度引用學(xué)科排名
書目名稱Clinical Cases in Atopic Dermatitis讀者反饋
書目名稱Clinical Cases in Atopic Dermatitis讀者反饋學(xué)科排名
作者: VEST 時(shí)間: 2025-3-21 20:30 作者: Indebted 時(shí)間: 2025-3-22 00:34 作者: Noctambulant 時(shí)間: 2025-3-22 06:57
AD and Psychodermatology/Quality of Life,ence of mental health disorders including depression, anxiety, and even thoughts of self-harm. Additionally, uncontrolled pruritus and the discomfort associated with atopic dermatitis can lead to sleep disturbance, which can worsen all of these factors. Stress and mental health symptoms can cause a 作者: 陪審團(tuán) 時(shí)間: 2025-3-22 12:16 作者: 嚴(yán)重傷害 時(shí)間: 2025-3-22 16:17
Treatment of AD with Non-pharmacological Interventions, and proactive use of moisturizers. Bathing techniques like the “soak and smear technique” can allow the skin to better retain moisture. Wet wrap therapy can provide significant relief to patients during atopic dermatitis flares, and a step-by-step method of how to perform wet wrap therapy is review作者: 嚴(yán)重傷害 時(shí)間: 2025-3-22 18:03 作者: 釘牢 時(shí)間: 2025-3-22 21:44 作者: flavonoids 時(shí)間: 2025-3-23 04:17
Treatment of Atopic Dermatitis with Phototherapy,aviolet B (UVB) phototherapy can also be used safely in pediatric, pregnant, and nursing populations. In this chapter, we will discuss the mechanism of action of phototherapy and review the safety and efficacy of broadband UVB (BB-UVB), NB-UVB, Goeckerman regimen (coal tar and UVB), excimer laser, p作者: MERIT 時(shí)間: 2025-3-23 08:21 作者: 富足女人 時(shí)間: 2025-3-23 12:41 作者: 補(bǔ)充 時(shí)間: 2025-3-23 17:38
Management of Facial Erythema on Dupilumab Treatment,lts and children, an emerging adverse effect of face and neck dermatitis has been reported in some patients. While there is an association with dupilumab use, the exact diagnosis and pathophysiology remain unclear. Conditions such as allergic contact dermatitis, rosacea-like conditions, and even top作者: 共棲 時(shí)間: 2025-3-23 21:44
Treatment of Erythrodermic Atopic Dermatitis with Cyclosporine,e is highly effective in treating erythrodermic atopic dermatitis and severe atopic dermatitis. Dosing of cyclosporine ranges from 2.5 to 5?mg/kg/day. Despite cyclosporine’s benefits, it has a lengthy side effect profile; the most significant concern is renal impairment. Additionally, cyclosporine r作者: oxidant 時(shí)間: 2025-3-23 23:22
Treatment of AD with Tralokinumab,evere pruritus, widespread eczematous lesions, pain, sleep disruption, anxiety, and depression. Although it is a relatively common disease affecting pediatric and adult patients alike, few options exist to treat moderate-to-severe AD. Janus kinase (JAK) inhibitors, including abrocitinib and upadacit作者: 舉止粗野的人 時(shí)間: 2025-3-24 05:05 作者: 落葉劑 時(shí)間: 2025-3-24 09:17 作者: nuclear-tests 時(shí)間: 2025-3-24 11:00
Treatment of Pediatric AD,rding use of systemic immunosuppressant medications in young patients. However, the medical management options for pediatric AD have evolved significantly in the past few years allowing for more targeted and effective systemic treatments. This chapter reviews both the current FDA-approved medication作者: ureter 時(shí)間: 2025-3-24 16:20
Atopic Dermatitis Spectrum Disorder, and the wide range of disease severity presents a diagnostic challenge to physicians and patients. Over ten diagnostic criteria comprising more than forty clinical manifestations of AD have been published. Missed diagnoses may contribute to prolonged patient suffering, undertreatment, difficulty wi作者: tattle 時(shí)間: 2025-3-24 21:14
Infection and AD Flares,ons occur in atopic dermatitis because the skin barrier is compromised and the production of antimicrobial peptides is decreased. The infection rate in atopic dermatitis is high and not only causes physical discomfort to the patient but also creates increased financial obligations for patients that 作者: 水槽 時(shí)間: 2025-3-24 23:30 作者: fiscal 時(shí)間: 2025-3-25 05:02 作者: Small-Intestine 時(shí)間: 2025-3-25 08:12
Multiple-Model Adaptive Control Approach,e to persist into adulthood. The pathophysiology of atopic dermatitis includes a dysfunctional epidermal barrier, skin microbiome abnormalities, and immune dysregulation. Features that are characteristic of the diagnosis are pruritic and eczematous lesions, which can present as acute, subacute, or c作者: Forehead-Lift 時(shí)間: 2025-3-25 14:42
Robust Control in Power Systemss and ethnicities; however, skin of color (SOC) patients with AD tend to have increased severity of the disease. There are genetic, psychosocial, and environmental hypotheses to account for the disparities in diagnosis, presentation, and prognosis of AD in SOC. SOC patients can experience diagnostic作者: ostracize 時(shí)間: 2025-3-25 16:01 作者: 類似思想 時(shí)間: 2025-3-25 22:35 作者: Unsaturated-Fat 時(shí)間: 2025-3-26 03:58 作者: 無能的人 時(shí)間: 2025-3-26 06:07 作者: 狼群 時(shí)間: 2025-3-26 09:14 作者: ferment 時(shí)間: 2025-3-26 13:48
Robust Control in Power Systemss of JAK inhibitors have been developed. Herein, we describe a case of a patient with mild atopic dermatitis who may benefit from use of the topical JAK inhibitor ruxolitinib. Ruxolitinib’s mechanism of action, efficacy in clinical trials, and safety profile are reviewed.作者: MURAL 時(shí)間: 2025-3-26 18:22 作者: adj憂郁的 時(shí)間: 2025-3-26 23:44
,Overview of Kharitonov’s Theorem, in the T helper 2 (Th2) immune response. It is FDA approved for the treatment of atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis, and eosinophilic esophagitis. For AD treatment, it is recommended for patients ≥6?months of age with moderate-to-severe disease who have not 作者: 小鹿 時(shí)間: 2025-3-27 03:33
,Overview of Kharitonov’s Theorem,which may result in corneal scarring. Vigorous eye rubbing alone contributes to serious ocular complications such as retinal detachment, keratoconus, and cataract. Treatment of atopic eye disease is based upon the severity of presentation and should aim to decrease recurrent flares of ocular inflamm作者: SHOCK 時(shí)間: 2025-3-27 07:58
Robust Control of Diesel Ship Propulsionlts and children, an emerging adverse effect of face and neck dermatitis has been reported in some patients. While there is an association with dupilumab use, the exact diagnosis and pathophysiology remain unclear. Conditions such as allergic contact dermatitis, rosacea-like conditions, and even top作者: modifier 時(shí)間: 2025-3-27 11:49
Robust Control of Diesel Ship Propulsione is highly effective in treating erythrodermic atopic dermatitis and severe atopic dermatitis. Dosing of cyclosporine ranges from 2.5 to 5?mg/kg/day. Despite cyclosporine’s benefits, it has a lengthy side effect profile; the most significant concern is renal impairment. Additionally, cyclosporine r作者: 噴出 時(shí)間: 2025-3-27 16:27
Ciprian Foias,Hitay ?zbay,Allen Tannenbaumevere pruritus, widespread eczematous lesions, pain, sleep disruption, anxiety, and depression. Although it is a relatively common disease affecting pediatric and adult patients alike, few options exist to treat moderate-to-severe AD. Janus kinase (JAK) inhibitors, including abrocitinib and upadacit作者: Silent-Ischemia 時(shí)間: 2025-3-27 18:39 作者: BOLUS 時(shí)間: 2025-3-28 00:13
https://doi.org/10.1007/BFb0027631 approved for both adolescents and adults for the treatment of moderate to severe atopic dermatitis who have failed or have contraindications to alternative systemic treatments. Upadacitinib is available in 15 and 30?mg, once daily doses. Clinical trials have demonstrated superior clinical efficacy 作者: MURAL 時(shí)間: 2025-3-28 03:28 作者: 上下倒置 時(shí)間: 2025-3-28 09:37
https://doi.org/10.1007/BFb0027631 and the wide range of disease severity presents a diagnostic challenge to physicians and patients. Over ten diagnostic criteria comprising more than forty clinical manifestations of AD have been published. Missed diagnoses may contribute to prolonged patient suffering, undertreatment, difficulty wi作者: meditation 時(shí)間: 2025-3-28 12:53
https://doi.org/10.1007/BFb0027631ons occur in atopic dermatitis because the skin barrier is compromised and the production of antimicrobial peptides is decreased. The infection rate in atopic dermatitis is high and not only causes physical discomfort to the patient but also creates increased financial obligations for patients that 作者: 粗鄙的人 時(shí)間: 2025-3-28 16:17 作者: SLAY 時(shí)間: 2025-3-28 20:58 作者: Frisky 時(shí)間: 2025-3-29 01:27 作者: subordinate 時(shí)間: 2025-3-29 06:15 作者: modest 時(shí)間: 2025-3-29 09:24
Clinical Cases in Dermatologyhttp://image.papertrans.cn/c/image/227846.jpg作者: 反叛者 時(shí)間: 2025-3-29 11:27 作者: SOB 時(shí)間: 2025-3-29 15:57 作者: 過分 時(shí)間: 2025-3-29 20:08
2730-6178 titis.?.?.Clinical Cases in Atopic Dermatitis .is a must-have resource for dermatologists, dermatology residents, fellows, medical students, nurse practitioners and physician assistants, as well as allergists and immunologists..978-3-031-52146-1978-3-031-52147-8Series ISSN 2730-6178 Series E-ISSN 2730-6186 作者: Gratuitous 時(shí)間: 2025-3-30 00:36 作者: 弄臟 時(shí)間: 2025-3-30 08:01
Infection and AD Flares,severity of infection. Eczema herpeticum, eczema coxsackium, and molluscum contagiosum are common viral infections that occur in atopic dermatitis, with specific diagnostics and treatments expanded upon in this chapter. The efficacy of bleach baths to alleviate atopic dermatitis symptoms as well as 作者: 星星 時(shí)間: 2025-3-30 09:01
2730-6178 ctice.Provides case-based narrative descriptions and patientThis concise practical guide is designed to facilitate the clinical decision-making process in the management of atopic dermatitis by reviewing a number of cases and defining the various diagnostic and management decisions open to clinician作者: 牽索 時(shí)間: 2025-3-30 15:25 作者: justify 時(shí)間: 2025-3-30 18:04 作者: 逗留 時(shí)間: 2025-3-30 22:41
Robust Control of Diesel Ship Propulsionmab use, the exact diagnosis and pathophysiology remain unclear. Conditions such as allergic contact dermatitis, rosacea-like conditions, and even topical steroid withdrawal have been posited as potential considerations. It is important to exclude other potential diagnoses on the differential before attributing it to the dupilumab itself.作者: Cardioversion 時(shí)間: 2025-3-31 03:16
Treatment of AD with Non-pharmacological Interventions,apy can provide significant relief to patients during atopic dermatitis flares, and a step-by-step method of how to perform wet wrap therapy is reviewed. Other non-pharmacologic treatments like exercise techniques, oils, and vitamins have been reported to be beneficial in limited capacities and are briefly reviewed.作者: Abduct 時(shí)間: 2025-3-31 08:13 作者: 迅速飛過 時(shí)間: 2025-3-31 10:40
Management of Facial Erythema on Dupilumab Treatment,mab use, the exact diagnosis and pathophysiology remain unclear. Conditions such as allergic contact dermatitis, rosacea-like conditions, and even topical steroid withdrawal have been posited as potential considerations. It is important to exclude other potential diagnoses on the differential before attributing it to the dupilumab itself.作者: Phenothiazines 時(shí)間: 2025-3-31 15:15
Control For Time-Delayed Systems,methods of investigation and diagnosis. Based on our current understanding, it appears that a compromised skin barrier and skin and gut microbiome dysbiosis are associated with both AD and FA. Lastly, the role of oral supplements and vitamins in the management of AD is discussed.作者: 似少年 時(shí)間: 2025-3-31 21:07
,Overview of Kharitonov’s Theorem,s glaucoma and cataract. Dupilumab, an effective medication for atopic dermatitis, can induce or exacerbate conjunctivitis. New ocular symptoms after dupilumab initiation warrant ophthalmology referral.作者: 公豬 時(shí)間: 2025-4-1 00:40
https://doi.org/10.1007/BFb0027631 short-term AD outcomes compared to dupilumab use. Coupled with minimal lab monitoring once the drug is initiated, abrocitinib can be considered as a systemic option in patients with moderate-to-severe AD to achieve their treatment goals.作者: Jingoism 時(shí)間: 2025-4-1 03:41
https://doi.org/10.1007/BFb0027631 for baseline lab monitoring prior to starting upadacitinib include a TB evaluation, viral hepatitis panel, complete blood count (CBC), liver enzymes, and lipid panel. Blood, liver, and lipid level monitoring after treatment initiation may be considered.作者: CYN 時(shí)間: 2025-4-1 06:18
AD, Environment, and Diet,methods of investigation and diagnosis. Based on our current understanding, it appears that a compromised skin barrier and skin and gut microbiome dysbiosis are associated with both AD and FA. Lastly, the role of oral supplements and vitamins in the management of AD is discussed.作者: Calculus 時(shí)間: 2025-4-1 13:41 作者: Optic-Disk 時(shí)間: 2025-4-1 17:59
